Dr. Leong is board certified in surgery and is a nationally recognized expert in melanoma. He specializes in selective sentinel lymph node dissections, and immunotherapy for patients with advanced melanoma.
Dr. Leong has lectured nationally and internationally on new advances in the treatment of malignant melanoma and the use of selective sentinel lymphadenectomy. As Associate Director of CPMC’s Center for Melanoma Research and Treatment, Dr. Leong collaborates with other investigators including Dr. Mohammed Kashani-Sabet on a new integrated research program at CPMCRI aimed at developing novel combination therapies for aggressive and metastatic tumors, including melanomas.
Sutter Health Research Enterprise
2340 Clay Street, 2nd Floor
San Francisco, CA, 94115
(415) 600-3800
LeongSX@Sutterhealth.org
Primary Research Interests
Related Clinical Trials
Castle DECIDE
DecisionDx-Melanoma Impact in Sentinel Lymph Node Biopsy Decisions and Clinical Outcomes
Investigator: Stanley Leong M.D.
Status: Active, Recruiting